Treatment of residual anxiety symptoms with adjunctive aripiprazole in depressed patients taking selective serotonin reuptake inhibitors

Journal of Affective Disorders

Volumn 86, Issue 1, 2005, Pages 99-104

  Adson, David E ^a   Kushner, Matt G ^a   Fahnhorst, Tamara A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Anxiety; Aripiprazole; Clinical trail; Depression; SSRIs

Indexed keywords

ARIPIPRAZOLE; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AKATHISIA; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; DEPRESSION; EXTRAPYRAMIDAL SYNDROME; HAMILTON SCALE; HEALTH STATUS; HUMAN; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RESTLESSNESS; SIDE EFFECT; SYMPTOMATOLOGY;

EID: 16844376388     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2004.11.007     Document Type: Article

References (21)

1. D.E. Adson, M.G. Kushner, K.M. Eiben, and C. Schulz Preliminary experience with adjunctive quetiapine in patients on selective serotonin reuptake inihibitors Depress. Anxiety 19 2004 121 126
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4th ed. Rev. 2000 Author Washington, DC
3. J.G. Barbee, E.J. Conrad, and N.J. Jamhour The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder J. Clin. Psychiatry 65 2004 975 981
4. S. Dube, S.A. Corya, S. Andersen, H. Detke, S. Blansette, and G.D. Tollefson Efficacy of Olanzapine/Fluoxetine combination in treatment-resistant depression 2002 Poster, American College of Neuropsychopharmacology San Juan, Puerto Rico
5. P.J. Goodnick, and J.M. Jerry Aripiprazole: profile on efficacy and safety Expert Opin. Pharmacother. 3 12 2002 1773 1781
6. J. Gorman, K. Shear, D. Cowley, C.D. Cross, J. March, and W. Roth Practice guidelines for the treatment of patients with panic disorder Am. J. Psychiatry 155 5 1998 1 33
7. S. Hirose, and C.R. Ashby Jr. An open pilot study combining risperidone and a selective serotonin reuptake inhibitor as initial antidepressant therapy J. Clin. Psychiatry 63 8 2002 733 736
8. T.B. Karasu, A. Gelenberg, A. Merriam, and P. Wang Practice guideline for the treatment of patients with major depressive disorder (revision) Am. J. Psychiatry 157 4 2000 1 45
9. P.E. Keck, R. Marcus, S. Tourkodimitris, M. Ali, A. Liebeskind, A. Saha, and G. Ingenito A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania Am. J. Psychiatry 160 2003 1651 1658
10. R.C. Kessler, K.A. McGonagle, S. Zhao, C.B. Nelson, M. Hughes, S. Eshleman, H. Wittchen, and K.S. Kendler Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States Arch. Gen. Psychiatry 51 1994 8 19
11. R.C. Kessler, P. Berglund, O. Demler, R. Jin, D. Koretz, K.R. Merikangas, A.J. Rush, E.E. Walters, and P.S. Wang The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA 289 23 2003 3095 3105
12. R.F. Krueger, and T.M. Piasecki Toward a dimensional and psychometrically-informed approach to conceptualizing psychopathology Behav. Res. Ther. 40 2002 485 499
13. M. Menza, H. Marin, and R.S. Opper Residual symptoms in depression: can treatment by symptom-specific? J. Clin. Psychiatry 64 2003 516 523
14. G.I. Papakostas, T.J. Petersen, A.A. Nierenberg, J.L. Murakami, I.E. Alpert, I.F. Rosenbaum, and M. Fava Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder J. Clin. Psychiatry 65 2 2004 217 221
15. G. Perugi, H.S. Akiskal, S. Ramacciotti, S. Nassini, C. Toni, A. Milanfranchi, and L. Musetti Depressive comorbidity of panic, social phobic, and obsessive-compulsive disorders re-examined: is there a bipolar II connection? J. Psy. Res. 33 1 1999 53 61
16. Physicians desk reference (PDR) 58th edition 2004 Thomson Healthcare Montvale, NJ
17. M.H. Rapaport Prevalence, recognition, and treatment of comorbid depression and anxiety J. Clin. Psychiatry 62 2001 6 10
18. S.M. Stahl Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder J. Clin. Psychiatry 63 9 2002 756 757
19. D.J. Stein, H.G. Westenberg, and M.R. Liebowitz Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry J. Clin. Psychiatry 63 2002 12 19
20. M. Thase Effectiveness of antidepressants: comparative remission rates J. Clin. Psychiatry 64 2 2003 3 7
21. K.A. Yonkers, S.E. Bruce, I.R. Dyck, and M.B. Keller Chronicity, relapse, and illness-course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up Depress. Anxiety 17 3 2003 173 179